Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Jason Gallagher Examines Antibiotic Development for Infectious Diseases Publication

View All News

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, Clinical Professor at the Temple University School of Pharmacy, Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy, addressed antibiotic development for the June issue of Contagion Live. Gallagher, who is the editor-in-chief of the news publication, focused on Achaogen, which had developed plazomicin and has since filed for bankruptcy, and what that could mean going forward.